A distribution business supplying GMP-grade mRNA and lipid nanoparticles to Japanese pharmaceutical companies under an exclusive distribution agreement with Vernal Biosciences. It covers the establishment of a domestic sales channel for products from an external company, rather than the development of the company's own DDS technology.